Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 06, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- March 1, 2006: Transfer of 14,143 Ordinary Shares.
- March 2, 2006: Transfer of 30,105 Ordinary Shares.
- Correction: A previous notification regarding a February 1, 2006 transaction was corrected; the actual number of shares transferred was 5,250, not the previously reported 7,350.
Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the GSK Trust as potential beneficiaries alongside other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the correction of the share count error.
Investor Verification Points
- Verify the corrected share count for the February 1, 2006 transaction (5,250 shares).
- Confirm the total volume of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 in early March 2006.
- Note that this filing does not reflect operational or financial performance metrics.